Kardigan, Inc.
NASDAQ:KARDBiotechnology
Healthcare
$12.32 +3.50%
+$0.77 today
- Market cap
- $1.10B
- Beta
- 0.00
52W Low $16.25High $24.00
Volume 0.55M
Average 5.84M
KARD Total Liabilities
Everything the company owes to creditors and other parties.
No reported Total Liabilities figures are available to summarize.
Total Liabilities history
Currency unavailable · from the balance sheet
No Total Liabilities data reported for this period type.
Total Liabilities vs competitors
How KARD compares with its peers on the latest reported figures
KARD Competitors
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $2.1B USD | +31.6% | +22.9% | 109.0% | |
| Jun 2026 | $73.03M USD | +99.5% | +21.0% | 10.4% | |
| Mar 2026 | $58.26M USD | — | — | 19.9% | |
| Mar 2026 | $28.88M USD | +17.6% | -12.7% | 21.4% | |
| Mar 2026 | $5.71M USD | -33.2% | +28.6% | 3.3% | |
| — | — | — | — | — | |
| Peer median (excluding KARD) | — | +24.6% | +22.0% | 19.9% | |
Competitors are the stored peer set for KARD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Currency unavailable
Kardigan, Inc.
NASDAQ:KARD
Intrinsic Alpha fair value
Locked
Current Price
$12.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.